Literature DB >> 20800702

Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom.

Nick Andrews1, Julia Stowe, Lesley Wise, Elizabeth Miller.   

Abstract

General practitioner consultation data were used to compare the reactogenicity in infants of a 5-in-1 acellular pertussis vaccine (DTaP(5)/Hib/IPV) introduced in the United Kingdom in 2004 to the 4-in-1 whole cell-pertussis vaccine (DTwP/Hib) that it replaced. For each vaccine the incidence in the week following vaccination was compared to other periods to obtain a relative incidence. A lower relative incidence of crying, fever and local reactions was seen with DTaP(5)/Hib/IPV than DTwP/Hib. Although there were no other significant differences between vaccines the relative incidence was significantly above one on the day of vaccination for convulsions following DTwP/Hib and for apnoea/collapse following DTaP(5)/Hib/IPV.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800702     DOI: 10.1016/j.vaccine.2010.08.062

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Infant sleep after immunization: randomized controlled trial of prophylactic acetaminophen.

Authors:  Linda Franck; Caryl L Gay; Mary Lynch; Kathryn A Lee
Journal:  Pediatrics       Date:  2011-11-28       Impact factor: 7.124

2.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

3.  DTaP(5)-IPV-Hib vaccine (Pediacel®).

Authors:  James E Frampton
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

4.  The use of relative incidence ratios in self-controlled case series studies: an overview.

Authors:  Steven Hawken; Beth K Potter; Julian Little; Eric I Benchimol; Salah Mahmud; Robin Ducharme; Kumanan Wilson
Journal:  BMC Med Res Methodol       Date:  2016-09-23       Impact factor: 4.615

5.  Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.

Authors:  Pedro L Moro; Silvia Perez-Vilar; Paige Lewis; Marthe Bryant-Genevier; Hajime Kamiya; Maria Cano
Journal:  Pediatrics       Date:  2018-06-04       Impact factor: 7.124

6.  Accelerating control of pertussis in England and Wales.

Authors:  Helen Campbell; Gayatri Amirthalingam; Nick Andrews; Norman K Fry; Robert C George; Timothy G Harrison; Elizabeth Miller
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

7.  Impact of the COVID-19 pandemic on Bordetella pertussis infections in England.

Authors:  Elise Tessier; Helen Campbell; Sonia Ribeiro; Yuma Rai; Simon Burton; Partho Roy; Norman K Fry; David Litt; Gayatri Amirthalingam
Journal:  BMC Public Health       Date:  2022-02-28       Impact factor: 3.295

8.  Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China.

Authors:  Xuejiao Pan; Huakun Lv; Hui Liang; Ying Wang; Linzhi Shen; Fuxing Chen; Yaping Chen; Yu Hu
Journal:  Hum Vaccin Immunother       Date:  2022-02-02       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.